Executive Vice President at Genentech Research and Early Development
Aviv Regev is the Executive Vice President at Genentech Research and Early Development, where she oversees all aspects of drug discovery and development. Before joining Genentech, she held several prominent roles at the Broad Institute of MIT and Harvard, including Chair of the Faculty and founding director of the Klarman Cell Observatory. She also served as a Professor of Biology at MIT and Investigator at the Howard Hughes Medical Institute. A leader in molecular circuit research, her lab has pioneered methods in single-cell genomics to better understand health and disease. Regev is a member of the National Academy of Sciences and the National Academy of Medicine and received the L’Oreal-UNESCO For Women In Science award in 2023. She holds a Ph.D. in computational biology and a Master of Science from Tel Aviv University.